Hemoglobin A2 and F Stabilization via pH and Buffer Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to stabilize different types of hemoglobins, such as HbA2 and HbF, simultaneously due to their varying molecular charges, making it difficult to maintain their stability over time.
Innovation Solution
A method involving the preparation of a solution with a specific pH range of 6.0 to 9.6, a buffer concentration of 5 to 150 mM, and a hemoglobin concentration of 5 to 20 g/L, which includes sucrose as a stabilizer, effectively stabilizes both HbA2 and HbF for extended periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If sucrose is added as a stabilizer, then hemoglobin stability is improved, but different types of hemoglobins (HbA2 and HbF) cannot be stabilized simultaneously due to their different molecular charges
Solution Approach 1:
The patent applies parameter changes by optimizing the pH range (6.0-9.6) and buffer concentration (5-150 mM) to create conditions where both HbA2 and HbF can be stabilized simultaneously by sucrose. This resolves the contradiction by modifying the chemical environment parameters to accommodate the different molecular charges of various hemoglobin types.
Solution Approach 2:
The patent achieves universality by developing a stabilization system that works for multiple hemoglobin types (HbA2 and HbF) using the same sucrose-based approach. The standardized solution formulation with specific pH and buffer conditions enables a single method to stabilize different hemoglobin variants, making the technique broadly applicable across various precision control substance applications.
2Duration of action of stationary object
If hemoglobin solutions are prepared for long-term stability, then storage duration is extended, but maintaining stability of multiple hemoglobin types becomes more difficult
Solution Approach 1:
The patent extends storage duration while maintaining stability by optimizing key parameters: pH (6.0-9.6), buffer concentration (5-150 mM), and sucrose concentration. These parameter adjustments create a stable chemical environment that prevents degradation of both HbA2 and HbF over extended storage periods, achieving long-term reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method ensures that HbA2 and HbF remain stable for at least 21 days when stored at 8°C, reducing variations in their proportions and enhancing the stability and usability of hemoglobin solutions as precision control substances.
Implementation Method 1
sucrose is contained as a stabilizer in a mixed hemolysate containing a hemolysate of human red blood cells and human umbilical cord blood
Implementation Method 2
preparing a solution containing a buffer, sucrose, and hemoglobin, wherein: the solution has a pH of from 6.0 to 9.6, a concentration of the buffer in the solution is from 5 to 150 mM
Data Source
Figure 1
Figure 2
AI summary
A method for stabilizing hemoglobin A2 and hemoglobin F and a method of producing a hemoglobin solution, the methods including preparing a solution containing a buffer, sucrose, and hemoglobin, wherein: the solution has a pH of from 6.0 to 9.6, a concentration of the buffer in the solution is from 5 to 150 mM, a concentration of the hemoglobin in the solution is from 5 to 20 g/L, and the hemoglobin contains at least hemoglobin A2 and hemoglobin F; and a hemoglobin solution, are provided.